Abbott Laboratories set to report Q1 FY26 earnings. Here’s what to expect
Abbott Laboratories (NYSE: ABT) enters fiscal 2026 with a growing profile, increasingly driven by sustained momentum in medical devices—particularly diabetes...
Featured
$ABT
Abbott Heads Into Earnings With Diagnostics in Focus
Abbott Laboratories (ABT) is due to report first-quarter 2026 results before the market opens on April 16, 2026, according to…
